semaglutide cas number Supplier | 910463-68-2 Semaglutide Intermediate P29 | Semaglutide

Safety Recommendations and When to Seek Alternative Approaches Most major lactation and pharmacology references recommend against semaglutide during breastfeeding due to insufficient safety data rather than proven harm

Long-term use of oral semaglutide may support sustained weight reduction while contributing to broader metabolic improvements

This guide covers all of it, built from clinical trial data, patient-reported protocols, and the kind of practical implementation detail that actually determines long-term outcomes

December 2025: On December 15, 2025, the Judicial Panel on Multidistrict Litigation entered an order approving the creation of an MDL to house federal vision loss claims for Wegovy and other GLP-1 drugs

February 2, 2026: Over 100 New Ozempic Lawsuits Filed Dozens of new lawsuits involving Ozempic and drugs like it have been filed in just the past few weeks